Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Traws Pharma, Inc. - Common Stock
(NQ:
TRAW
)
4.865
+0.165 (+3.51%)
Streaming Delayed Price
Updated: 3:54 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Traws Pharma, Inc. - Common Stock
Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil
October 08, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
September 30, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
September 20, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma, Inc. Announces Special Shareholders Meeting Results
September 17, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
August 15, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
August 14, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
May 23, 2024
Differentiated resistance profile positions Traws’ program as a potential class leader
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
May 16, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
May 07, 2024
From
Traws Pharma, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.